Molecular epidemiology of RAS/RAF-mutant colorectal cancer metastases

被引：0
|
作者：
Atreya, Chloe Evelyn
Watters, James
Rowley, Steve
Lee, Joon Sang
Iartchouk, Oleg
Light, Madelyn
Warren, Robert S.
Venook, Alan Paul
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Sanofi Oncol, Cambridge, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.470
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
470
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Exploiting c-RAF dependency in RAS mutant cancer: beyond catalytic activity
    Cooke, Sean F.
    Blair, Connor M.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (3-4) : 95 - 100
  • [32] Development of a dual inhibitor of pan-RAF and VEGFR2 for the treatment of metastatic colorectal cancer with mutant K-RAS
    Hong, Sungpyo
    Choi, Young-Il
    Choi, Jihye
    Kim, Wonyoung
    Kwon, Ho-Seok
    Park, Yong Bin
    Ki, Min-Hyo
    Shin, Hee Jong
    Lee, Michael
    Ahn, Soon Kil
    CANCER RESEARCH, 2016, 76
  • [33] Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
    Xinyi Zhou
    Qian Xiao
    Dongliang Fu
    Haochen Zhang
    Yang Tang
    Jinjie He
    Yeting Hu
    Xiangxing Kong
    Fei Teng
    Xiangrui Liu
    Ying Yuan
    Kefeng Ding
    Cancer Biology & Medicine, 2022, (02) : 213 - 228
  • [34] Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
    Zhou, Xinyi
    Xiao, Qian
    Fu, Dongliang
    Zhang, Haochen
    Tang, Yang
    He, Jinjie
    Hu, Yeting
    Kong, Xiangxing
    Teng, Fei
    Liu, Xiangrui
    Yuan, Ying
    Ding, Kefeng
    CANCER BIOLOGY & MEDICINE, 2022, 19 (02) : 213 - +
  • [35] Molecular dynamics simulations of the Ras:Raf and Rap:Raf complexes
    Zeng, J
    Treutlein, HR
    Simonson, T
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 1999, 35 (01) : 89 - 100
  • [36] Undetectable RAS mutant clones in plasma: Possible implication for therapy and prognosis in the patient with RAS mutant metastatic colorectal cancer?
    Bouchahda, M.
    Karaboue, A.
    Saffroy, R.
    Hamelin, J.
    Bosselut, N.
    Lemoine, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [37] Epidemiology of colorectal liver metastases
    McMillan, Donald C.
    McArdle, Colin S.
    SURGICAL ONCOLOGY-OXFORD, 2007, 16 (01): : 3 - 5
  • [38] Mutational status in Ras/Raf/MAPK signaling pathway in Moroccan colorectal cancer patients
    Sqalli Houssaini, M.
    Damou, M.
    Guessous, F.
    Ismaili, N.
    ANNALS OF ONCOLOGY, 2020, 31 : S206 - S206
  • [39] RAS/RAF mutations and their associations with epigenetic alterations for distinct pathways in Vietnamese colorectal cancer
    To Van Ta
    Quang Ngoc Nguyen
    Ha Hoang Chu
    Van-Long Truong
    Linh Dieu Vuong
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (04)
  • [40] Mutant allele specific imbalance in RAS as prognostic marker in colorectal cancer
    Kirshenboim, Y.
    Birenboim, M.
    Hershkovitz, D.
    Geva, R.
    Mendlovic, S.
    Leibowitz, R.
    Yarom, N.
    ANNALS OF ONCOLOGY, 2021, 32 : S195 - S196
12345